Cargando…
Societal costs of chemotherapy in the UK: an incidence-based cost-of-illness model for early breast cancer
AIM: To estimate annual societal costs associated with chemotherapy for early breast cancer in the UK. DESIGN: Mixed methods: (a) an incidence-based cost-of-illness model was developed of indirect costs in patients with breast cancer and carers, and estimated from diagnosis through active treatment...
Autores principales: | Parsekar, Krishnali, Howard Wilsher, Stephanie, Sweeting, Anna, Patel, Anita, Fordham, Richard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8728345/ https://www.ncbi.nlm.nih.gov/pubmed/33431487 http://dx.doi.org/10.1136/bmjopen-2020-039412 |
Ejemplares similares
-
Monetary costs of agitation in older adults with Alzheimer's disease in the UK: prospective cohort study
por: Morris, Stephen, et al.
Publicado: (2015) -
Can we reduce costs and prevent more unintended pregnancies? A cost of illness and cost-effectiveness study comparing two methods of EHC
por: Thomas, Christine M, et al.
Publicado: (2013) -
Cost of the COVID-19 pandemic versus the cost-effectiveness of mitigation strategies in EU/UK/OECD: a systematic review
por: Vardavas, Constantine, et al.
Publicado: (2023) -
The economic benefit of hip replacement: a 5-year follow-up of costs and outcomes in the Exeter Primary Outcomes Study
por: Fordham, Richard, et al.
Publicado: (2012) -
Economic impact of delirium in Australia: a cost of illness study
por: Pezzullo, Lynne, et al.
Publicado: (2019)